Abstract
In melanoma, intratumoral T-VEC is thought to work through viral replication and destruction of cancer cells, thereby stimulating an immune response. In this issue of Cancer Cell, Ramelyte etal. show activity of T-VEC incutaneous B cell lymphoma and demonstrate, using scRNA-seq, that viral replication occurs not only in tumor cells.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
